• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RUNX1增强子在正常造血和白血病发生中的作用。

Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.

作者信息

Liau Wei-Siang, Ngoc Phuong Cao Thi, Sanda Takaomi

机构信息

Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.

Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.

出版信息

Adv Exp Med Biol. 2017;962:139-147. doi: 10.1007/978-981-10-3233-2_10.

DOI:10.1007/978-981-10-3233-2_10
PMID:28299656
Abstract

Enhancers are regulatory elements in genomic DNA that contain specific sequence motifs that are bound by DNA-binding transcription factors. The activity of enhancers is tightly regulated in an integrated and combinatorial manner, thus yielding complex patterns of transcription in different tissues. Identifying enhancers is crucial to understanding the physiological and pathogenic roles of their target genes. The RUNX1 intronic enhancer, eR1, acts in cis to regulate RUNX1 gene expression in hematopoietic stem cells (HSCs) and hemogenic endothelial cells. RUNX1 and other hematopoietic transcription factors TAL1/SCL, GATA2, PU.1, LMO2 and LDB1 bind at this region. Interestingly, recent studies have revealed that this region is involved in a large cluster of enhancers termed a super-enhancer. The RUNX1 super-enhancer is observed in normal HSCs and T-cell acute lymphoblastic leukemia cells. In this review, we describe the discovery of eR1 and its roles in normal development and leukemogenesis, as well as its potential applications in stem cell research.

摘要

增强子是基因组DNA中的调控元件,包含特定的序列基序,可被DNA结合转录因子结合。增强子的活性以整合和组合的方式受到严格调控,从而在不同组织中产生复杂的转录模式。鉴定增强子对于理解其靶基因的生理和致病作用至关重要。RUNX1内含子增强子eR1顺式作用于造血干细胞(HSC)和造血内皮细胞中RUNX1基因的表达。RUNX1和其他造血转录因子TAL1/SCL、GATA2、PU.1、LMO2和LDB1结合在该区域。有趣的是,最近的研究表明,该区域参与了一大群被称为超级增强子的增强子。在正常造血干细胞和T细胞急性淋巴细胞白血病细胞中观察到RUNX1超级增强子。在这篇综述中,我们描述了eR1的发现及其在正常发育和白血病发生中的作用,以及其在干细胞研究中的潜在应用。

相似文献

1
Roles of the RUNX1 Enhancer in Normal Hematopoiesis and Leukemogenesis.RUNX1增强子在正常造血和白血病发生中的作用。
Adv Exp Med Biol. 2017;962:139-147. doi: 10.1007/978-981-10-3233-2_10.
2
SCL/TAL1 in Hematopoiesis and Cellular Reprogramming.造血和细胞重编程中的SCL/TAL1
Curr Top Dev Biol. 2016;118:163-204. doi: 10.1016/bs.ctdb.2016.01.004. Epub 2016 Feb 18.
3
Hematopoietic stem cell enhancer: a powerful tool in stem cell biology.造血干细胞增强子:干细胞生物学中的强大工具。
Histol Histopathol. 2015 Jun;30(6):661-72. doi: 10.14670/HH-30.661. Epub 2015 Jan 9.
4
A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells.Runx1 内含子增强子标记造血内皮细胞和造血干细胞。
Stem Cells. 2010 Oct;28(10):1869-81. doi: 10.1002/stem.507.
5
HOXB4 Promotes Hemogenic Endothelium Formation without Perturbing Endothelial Cell Development.HOXB4 促进造血内皮细胞的形成,而不干扰内皮细胞的发育。
Stem Cell Reports. 2018 Mar 13;10(3):875-889. doi: 10.1016/j.stemcr.2018.01.009. Epub 2018 Feb 15.
6
Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1.组蛋白伴侣HIRA在转录因子RUNX1调控中的作用
J Biol Chem. 2015 May 22;290(21):13053-63. doi: 10.1074/jbc.M114.615492. Epub 2015 Apr 6.
7
A Runx1-Smad6 rheostat controls Runx1 activity during embryonic hematopoiesis.Runx1-Smad6 变阻器控制胚胎造血过程中 Runx1 的活性。
Mol Cell Biol. 2011 Jul;31(14):2817-26. doi: 10.1128/MCB.01305-10. Epub 2011 May 16.
8
A DNA Contact Map for the Mouse Runx1 Gene Identifies Novel Haematopoietic Enhancers.一种用于小鼠 Runx1 基因的 DNA 接触图谱鉴定出新型造血增强子。
Sci Rep. 2017 Oct 17;7(1):13347. doi: 10.1038/s41598-017-13748-8.
9
Mathematical model of a gene regulatory network reconciles effects of genetic perturbations on hematopoietic stem cell emergence.基因调控网络的数学模型协调了遗传扰动对造血干细胞出现的影响。
Dev Biol. 2013 Jul 15;379(2):258-69. doi: 10.1016/j.ydbio.2013.04.016. Epub 2013 Apr 23.
10
Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer.Runx1介导的造血干细胞出现受Gata/Ets/SCL调控的增强子控制。
Blood. 2007 Dec 15;110(13):4188-97. doi: 10.1182/blood-2007-07-100883. Epub 2007 Sep 6.

引用本文的文献

1
RUNX1 isoforms regulate RUNX1 and target genes differentially in platelets-megakaryocytes: association with clinical cardiovascular events.RUNX1 异构体在血小板-巨核细胞中差异调节 RUNX1 和靶基因:与临床心血管事件的关联。
J Thromb Haemost. 2024 Dec;22(12):3581-3598. doi: 10.1016/j.jtha.2024.07.032. Epub 2024 Aug 23.
2
Super-enhancer omics in stem cell.干细胞中的超级增强子组学。
Mol Cancer. 2024 Aug 1;23(1):153. doi: 10.1186/s12943-024-02066-z.
3
RUNX1 Isoforms Regulate RUNX1 and Target-Genes Differentially in Platelets-Megakaryocytes: Association with Clinical Cardiovascular Events.
RUNX1 异构体在血小板 - 巨核细胞中对 RUNX1 和靶基因有不同的调控作用:与临床心血管事件的关联
bioRxiv. 2024 Jun 21:2024.06.18.599563. doi: 10.1101/2024.06.18.599563.
4
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2.用蛋白翻译抑制剂和 BCL2 联合治疗 RUNX1 突变的 AML 具有疗效。
Blood. 2022 Feb 10;139(6):907-921. doi: 10.1182/blood.2021013156.
5
Multi-Omics and Informatics Analysis of FFPE Tissues Derived from Melanoma Patients with Long/Short Responses to Anti-PD1 Therapy Reveals Pathways of Response.对接受抗PD1治疗有长/短反应的黑色素瘤患者的FFPE组织进行多组学和信息学分析揭示了反应途径。
Cancers (Basel). 2020 Nov 26;12(12):3515. doi: 10.3390/cancers12123515.
6
Low-pass whole genome bisulfite sequencing of neonatal dried blood spots identifies a role for RUNX1 in Down syndrome DNA methylation profiles.新生儿干血斑的低通全基因组亚硫酸氢盐测序确定了RUNX1在唐氏综合征DNA甲基化谱中的作用。
Hum Mol Genet. 2021 Jan 6;29(21):3465-3476. doi: 10.1093/hmg/ddaa218.
7
GATA2 +9.5 enhancer: from principles of hematopoiesis to genetic diagnosis in precision medicine.GATA2 +9.5 增强子:从造血原理到精准医学中的遗传诊断。
Curr Opin Hematol. 2020 May;27(3):163-171. doi: 10.1097/MOH.0000000000000576.
8
The RUNX1 Enhancer Element eR1: A Versatile Marker for Adult Stem Cells.RUNX1 增强子元件 eR1:成体干细胞的多功能标志物。
Mol Cells. 2020 Feb 29;43(2):121-125. doi: 10.14348/molcells.2019.0250.
9
RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.针对 AML 中存在 RUNX1 体细胞或种系突变的 RUNX1 靶向治疗。
Blood. 2019 Jul 4;134(1):59-73. doi: 10.1182/blood.2018893982. Epub 2019 Apr 25.
10
The Role of TAL1 in Hematopoiesis and Leukemogenesis.TAL1在造血作用和白血病发生中的作用。
Acta Naturae. 2018 Jan-Mar;10(1):15-23.